CORONANSECORONA Remedies LimitedMinimalNeutral
Announced Tue, 7 Apr · 18:16 IST

CORONA Remedies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

CORONA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.2%1-day move
₹1517.00
prior close
₹1550.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.9-1.1+0.0+3.2+3.2+3.8+3.6+4.2+11.8+14.0+11.1+15.2+30.9
Up moveDown movePending
AI summary

Corona Remedies has submitted a quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The certificate was issued by Bigshare Services Private Limited, the company's Registrar and Share Transfer Agent. Notably, the RTA has confirmed that this regulation is not applicable to the company because the entire shareholding of Corona Remedies is already held in dematerialised (demat) form. Additionally, no shareholder requests for rematerialisation or dematerialisation were received during the quarter (January 1 to March 31, 2026). This is a routine regulatory filing with no change in business or shareholding structure.

Likely market impact

No material impact on shareholders or the stock price. This is a standard quarterly compliance disclosure confirming that all company shares are already in demat form, indicating good corporate housekeeping and full digitisation of shareholding.